Get the Stockscreener App
71.66
0.76%
0.055
Genedx Holdings Corp stock is traded at $71.66, with a volume of 33,165.
It is up +0.76% in the last 24 hours and up +36.00% over the past month.
GeneDx Holdings Corp focuses on genomics, creating the foundation for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. The company believes exome and genome testing will become the standard for diagnosing genetic disease, with the potential to transform healthcare from reactive to proactive. It aims to advance precision medicine by offering genetic diagnoses at the earliest moments, driving improved outcomes, and fueling discovery with genomic intelligence. Its operating segment mainly provides pediatric and rare disease diagnostics, focusing on whole exome and genome sequencing and, to a lesser extent, data and information services.
See More
Previous Close:
$71.71
Open:
$72.28
24h Volume:
33,165
Relative Volume:
0.03
Market Cap:
$2.13B
Revenue:
$442.68M
Net Income/Loss:
$-77.81M
P/E Ratio:
-26.85
EPS:
-2.6684
Net Cash Flow:
$-28.65M
1W Performance:
+5.22%
1M Performance:
+36.00%
6M Performance:
-45.39%
1Y Performance:
-19.53%
1-Day Range:
$71.35
$72.95
1-Week Range:
$67.33
$72.95
52-Week Range:
$32.21
$170.87
Genedx Holdings Corp Stock (WGS) Company Profile
Name
Genedx Holdings Corp
Sector
Industry
Phone
888-729-1206
Address
333 LUDLOW STREET, STAMFORD
Compare WGS vs TMO, DHR, IDXX, NTRA, A
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
WGS
Genedx Holdings Corp
|
71.65 | 2.04B | 442.68M | -77.81M | -28.65M | -2.6684 |
TMO
Thermo Fisher Scientific Inc
|
522.40 | 186.32B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
195.45 | 134.82B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
542.15 | 41.53B | 4.45B | 1.10B | 1.06B | 13.59 |
NTRA
Natera Inc
|
276.47 | 38.88B | 2.50B | -226.32M | 71.51M | -1.6412 |
A
Agilent Technologies Inc
|
133.56 | 37.52B | 7.23B | 1.41B | 1.09B | 4.979 |
Genedx Holdings Corp Stock (WGS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-09-26 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Oct-20-25 | Initiated | Canaccord Genuity | Buy |
| Jul-09-25 | Initiated | Piper Sandler | Overweight |
| May-15-25 | Initiated | Guggenheim | Buy |
| May-09-25 | Upgrade | Jefferies | Hold → Buy |
| Aug-28-24 | Initiated | Wells Fargo | Equal Weight |
| Jul-10-24 | Initiated | Craig Hallum | Buy |
| Jun-03-24 | Resumed | Jefferies | Hold |
View All
Genedx Holdings Corp Stock (WGS) Latest News
GeneDx Holdings Corp. (WGS) Class Action Lawsuit Seeks Recovery for Investors; August 3, 2026, DeadlineContact Kessler Topaz Meltzer & Check, LLP - PR Newswire
WGS Stockholders Have Rights – If You Lost Money Investing - GlobeNewswire
GeneDx (WGS) president receives 35,441 restricted stock units in new equity award - Stock Titan
HBSS Investigates Claims Against GeneDx Holdings (WGS) in Securities Class Action Suit Following Massive Impairment Charge - TMX Newsfile
Bronstein, Gewirtz & Grossman LLC Urges GeneDx Holdings - GlobeNewswire
WGS DEADLINE: Levi & Korsinsky Reminds GeneDx Holdings Corp. Investors of Upcoming Securities Class Action Deadline - PR Newswire
GeneDx Holdings Corp. Warrant -on GeneDx Holdings Financial Disclosures & SEC Filings - TradingView
GENEDX HOLDINGS CORP. INVESTORS WITH LOSSES HAVE UNTIL - GlobeNewswire
Important Notice to Long-Term Shareholders of GeneDx - GlobeNewswire
UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds GeneDx (WGS) Inve - The National Law Review
2026-07-01 | WGS SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that GeneDx Holdings Corp. Shareholders Have Opportunity to Lead Class Action Lawsuit | NDAQ:WGS | Press Release - Stockhouse
GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock Decline - GlobeNewswire Inc.
WGS Faruqi & Faruqi, LLP Reminds GeneDx (WGS) Investors of Securities Class Action Lawsuit Deadline on August 3, 2026 - marketscreener.com
HBSS Investigates Claims Against GeneDx Holdings (WGS) in Securities Class Action Suit Following Massive Impairment Charge - GlobeNewswire Inc.
WGS INVESTOR DEADLINE: GeneDx Holdings Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitRGRD Law - marketscreener.com
Bragar Eagel & Squire, P.C. Reminds Investors that a Class - GlobeNewswire
(WGS) Volatility Zones as Tactical Triggers - Stock Traders Daily
Kessler Topaz Meltzer & Check, LLP - GlobeNewswire Inc.
WGS SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that GeneDx Holdings Corp. Investors Have Opportunity to Lead Class Action Lawsuit - ACCESS Newswire
WGSGeneDx Holdings Corp Options - Finviz
GENEDX HOLDINGS CORP (WGS) Stock Chart - ChartMill
WGS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that GeneDx Holdings Corp. Shareholders Have Opportunity to Lead Class Action Lawsuit - ACCESS Newswire
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages GeneDx Holdings Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff - GlobeNewswire
WGS Maintained by Guggenheim -- Price Target Raised to $74 - GuruFocus
WGS INVESTOR ALERT: GeneDx Holdings Corp. Investors with Substan - GuruFocus
WGS INVESTOR ALERT: GeneDx Holdings Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - PR Newswire
Is GeneDx (WGS) Elevating Execution Risk or Opportunity With Its New Genomics-Focused President? - Sahm
Important Notice to Long-Term Shareholders of Badger Meter, - GlobeNewswire
WGS Investors Have Opportunity to Lead GeneDx Holdings Corp. Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire
ROSEN, A TOP RANKED LAW FIRM, Encourages GeneDx Holdings Corp. Investors to Secure Counsel Before Important Deadline in Securities Class ActionWGS - TMX Newsfile
WGS INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds GeneDx (WGS) Investors of Securities Class Action Lawsuit Deadline on August 3, 2026 - marketscreener.com
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages GeneDx Holdings Corp. Investors to Secure Counsel Before Important Deadline in Securities Class ActionWGS - TMX Newsfile
WGS Investors Have Opportunity to Lead GeneDx Holdings Corp. Securities Fraud Lawsuit - PR Newswire
Investor Alert: Deadline Approaching to Join GeneDx Holdings Corp. (WGS) Class ActionContact Levi & Korsinsky - ACCESS Newswire
ROSEN, A LEADING NATIONAL FIRM, Encourages GeneDx Holdings Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
INVESTOR DEADLINE ALERT: GeneDx Holdings Corp. (WGS) Investors With Substantial Losses Have Opportunity to Lead Class Action Lawsuit - NewMediaWire
HBSS Investigates Claims Against GeneDx Holdings (WGS) in - GlobeNewswire
WGS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that GeneDx Holdings Corp. Investors Have Opportunity to Lead Class Action Lawsuit - ACCESS Newswire
WGS Deadline Alert: The Gross Law Firm Reminds GeneDx - GlobeNewswire
WGS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announce - The National Law Review
GeneDx Holdings Corp. Class A Actuals & Estimates (NASDAQ:WGS) - TradingView
Recover Investment Losses: Class Action Initiated Against GeneDx Holdings Corp. (WGS) - ACCESS Newswire
August 3, 2026 Deadline: Join Class Action Lawsuit Against GeneDx Holdings Corp. (WGS)Contact Levi & Korsinsky - ACCESS Newswire
GeneDx Holdings (WGS) Faces Securities Class Action After 49% Dr - GuruFocus
Investors Urged to Contact Levi & Korsinsky for Information Before August 3, 2026GeneDx Holdings Corp. (WGS) - ACCESS Newswire
GeneDx Holdings Corp. (WGS) Investors: August 3, 2026, Deadline in Securities Fraud Class Action Lawsuit - GuruFocus
WGS Forecast — Price Target — Prediction for 2027 - TradingView
Shareholders of GeneDx Holdings Corp. (WGS): Protect Your Rights Before August 3, 2026Contact Levi & Korsinsky - ACCESS Newswire
WGS SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that GeneDx Holdings Corp. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit - ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in GeneDx Holdings Corp. of Class Action Lawsuit and Upcoming DeadlinesWGS - PR Newswire
Genedx Holdings Corp Stock (WGS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.00%
0.87%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):